MedPath

Validation research of improvement effects on cognition by test-food intakes

Not Applicable
Conditions
Healthy male/female adults
Registration Number
JPRN-UMIN000050693
Lead Sponsor
CPCC Company Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
76
Inclusion Criteria

Not provided

Exclusion Criteria

Subjects - - (1) who take steadily (not less than four times a week) in medicines (e.g., herbal), foods (e.g., bluefish) and supplements (e.g., DHA, EPA), which might affect human cognitive functions, (2) who have used (not less than four times a week) an affecting apparatus/application, (3) suffering from dementia, (4) with previous and/or current medical history of mental diseases (e.g., depression), (5) diagnosed as attention deficit hyperactivity disorder, (6) with color deficiency, (7) being under the restriction of carbohydrate with dieting, (8) with extremely irregular eating habits, (9) restricting their mealtimes to no more than once a day (not less than once a week), within the last month, (10) with excessive alcohol intake, (11) having a habit of smoking, (12) planning to vaccinate after the pre-test to the hospital visiting (12 W), (13) who will be under a variable condition, such as dietary habits, house-moving, transfer, (14) whose roomer will partake in this research, (15) being severe anemic, (16) with significant changes of their menopausal physical condition, (17) being under another clinical test with medicine or health food, or partook in that within the past 4 weeks, or will partake in that after giving informed consent, (18) having previous/current medical history of severe cardiac, hepatic, renal or digestive diseases, (19) with pregnancy, possibly one, or lactating, (20) having drug and food allergy (especially to wheat, egg, milk and soybean), (21) who donated their blood components or blood (0.2 L) within the last month, (22) who donated his blood (0.4 L) within the past 3 months, (23) who donated her blood (0.4 L) within the past 4 months, (24) being collected in total of his blood (1.2 L) within the past 12 months and in this research, (25) being collected in total of her blood (0.8 L) within the past 12 months and in this research, (26) determined as ineligible for participation, judging from the principal/sub investigator - - .

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath